Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2021 Jun 28

PMID 34177963

Citations 40

Authors

Lucia Lee

Kate Samardzic

Michael Wallach

Lyn R Frumkin

Daria Mochly-Rosen

Affiliations

Soon will be listed here.

Abstract

Antiviral, antibacterial, and antiparasitic drugs and vaccines are essential to maintaining the health of humans and animals. Yet, their production can be slow and expensive, and efficacy lost once pathogens mount resistance. Chicken immunoglobulin Y (IgY) is a highly conserved homolog of human immunoglobulin G (IgG) that has shown benefits and a favorable safety profile, primarily in animal models of human infectious diseases. IgY is fast-acting, easy to produce, and low cost. IgY antibodies can readily be generated in large quantities with minimal environmental harm or infrastructure investment by using egg-laying hens. We summarize a variety of IgY uses, focusing on their potential for the detection, prevention, and treatment of human and animal infections.

Citing Articles

Ultra-sensitive immunosensing of snake venom by functionalized Sm-Co doped antimony-tungstate.

Batool R, Shaheen S, Fatima B, Hussain D, Jawad U, Alam A Appl Microbiol Biotechnol. 2025; 109(1):55.

PMID: 40025373 PMC: 11872980. DOI: 10.1007/s00253-025-13437-x.

Avian Antibodies as Potential Therapeutic Tools.

Eriksson M, Larsson A Antibodies (Basel). 2025; 14(1).

PMID: 39982233 PMC: 11843883. DOI: 10.3390/antib14010018.

Growth-Inhibitory Effect of Chicken Egg Yolk Polyclonal Antibodies (IgY) on Zoonotic Pathogens , spp. and , In Vitro.

Czoska P, Tarsalewska K, Ponichtera M, Rybicka M, Sowa-Rogozinska N, Sominka-Pierzchlewicz H Int J Mol Sci. 2025; 26(3).

PMID: 39940808 PMC: 11816624. DOI: 10.3390/ijms26031040.

Evidence of avian and human influenza A virus infection in farmed Siamese crocodiles (Crocodylus siamensis) in Thailand.

Thongdee M, Chaiwattanarungruengpaisan S, Ketchim N, Sangkachai N, Arya N, Sirimanapong W PLoS One. 2025; 20(1):e0317035.

PMID: 39774465 PMC: 11706503. DOI: 10.1371/journal.pone.0317035.

Comparison of immunoglobulin Y antibody production in new and spent laying hens.

Metheenukul P, Surachetpong W, Prasertsincharoen N, Arreesrisom P, Thengchaisri N Vet World. 2024; 17(9):2177-2184.

PMID: 39507799 PMC: 11536739. DOI: 10.14202/vetworld.2024.2177-2184.

References

Omata M, Uchiumi K, Ito Y, Yokosuka O, Mori J, Terao K . Duck hepatitis B virus and liver diseases. Gastroenterology. 1983; 85(2):260-7. View

Nguyen H, Tumpey T, Park H, Byun Y, Tran L, Nguyen V . Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice. PLoS One. 2010; 5(4):e10152. PMC: 2854139. DOI: 10.1371/journal.pone.0010152. View

Carlander D, Kollberg H, Wejaker P, Larsson A . Peroral immunotherapy with yolk antibodies for the prevention and treatment of enteric infections. Immunol Res. 2000; 21(1):1-6. PMC: 7090601. DOI: 10.1385/ir:21:1:1. View

Li X, Jing K, Wang X, Li Y, Zhang M, Li Z . Protective effects of chicken egg yolk antibody (IgY) against experimental Vibrio splendidus infection in the sea cucumber (Apostichopus japonicus). Fish Shellfish Immunol. 2015; 48:105-11. DOI: 10.1016/j.fsi.2015.11.024. View

Terzolo H, Sandoval V, Caffer M, Terragno R, Alcain A . [Agglutination of hen egg-yolk immunoglobulins (IgY) against Salmonella enterica, serovar enteritidis]. Rev Argent Microbiol. 1998; 30(2):84-92. View

Henderson A, Nimmo G . Control of healthcare- and community-associated MRSA: recent progress and persisting challenges. Br Med Bull. 2017; 125(1):25-41. DOI: 10.1093/bmb/ldx046. View

Jernigan J, Hatfield K, Wolford H, Nelson R, Olubajo B, Reddy S . Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012-2017. N Engl J Med. 2020; 382(14):1309-1319. PMC: 10961699. DOI: 10.1056/NEJMoa1914433. View

Ferguson N, Galvani A, Bush R . Ecological and immunological determinants of influenza evolution. Nature. 2003; 422(6930):428-33. DOI: 10.1038/nature01509. View

Larsson A, Wejaker P, Forsberg P, Lindahl T . Chicken antibodies: a tool to avoid interference by complement activation in ELISA. J Immunol Methods. 1992; 156(1):79-83. DOI: 10.1016/0022-1759(92)90013-j. View

10.

Nomura S, Suzuki H, Masaoka T, Kurabayashi K, Ishii H, Kitajima M . Effect of dietary anti-urease immunoglobulin Y on Helicobacter pylori infection in Mongolian gerbils. Helicobacter. 2005; 10(1):43-52. DOI: 10.1111/j.1523-5378.2005.00290.x. View

11.

. Dengue vaccine: WHO position paper, September 2018 - Recommendations. Vaccine. 2018; 37(35):4848-4849. DOI: 10.1016/j.vaccine.2018.09.063. View

12.

Shin J, Yang M, Nam S, Kim J, Myung N, Bang W . Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter pylori infection. Clin Diagn Lab Immunol. 2002; 9(5):1061-6. PMC: 120060. DOI: 10.1128/cdli.9.5.1061-1066.2002. View

13.

Nothaft H, Davis B, Lock Y, Perez-Munoz M, Vinogradov E, Walter J . Engineering the Campylobacter jejuni N-glycan to create an effective chicken vaccine. Sci Rep. 2016; 6:26511. PMC: 4879521. DOI: 10.1038/srep26511. View

14.

Shen H, Cai Y, Zhang H, Wu J, Ye L, Yang P . Anti-SARS-CoV-2 IgY Isolated from Egg Yolks of Hens Immunized with Inactivated SARS-CoV-2 for Immunoprophylaxis of COVID-19. Virol Sin. 2021; 36(5):1080-1082. PMC: 8137804. DOI: 10.1007/s12250-021-00371-1. View

15.

Zaki S, Greer P, Coffield L, Goldsmith C, Nolte K, Foucar K . Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol. 1995; 146(3):552-79. PMC: 1869168. View

16.

Takeuchi S, Motohashi J, Kimori H, Nakagawa Y, Tsurumoto A . Effects of oral moisturising gel containing egg yolk antibodies against Candida albicans in older people. Gerodontology. 2014; 33(1):128-34. DOI: 10.1111/ger.12139. View

17.

Wang X, Fan B, Liu L, Hu X, Li R, Wei Y . In vitro inhibition of oral Candida albicans by chicken egg yolk antibody (IgY). Mycopathologia. 2008; 165(6):381-7. DOI: 10.1007/s11046-008-9097-0. View

18.

Smith T, Pearson M, WILCOX K, Cruz C, Lancaster M, Robinson-Dunn B . Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med. 1999; 340(7):493-501. DOI: 10.1056/NEJM199902183400701. View

19.

de Groot R, Baker S, Baric R, Brown C, Drosten C, Enjuanes L . Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol. 2013; 87(14):7790-2. PMC: 3700179. DOI: 10.1128/JVI.01244-13. View

20.

Pinto D, Vinayak S . : Host-Parasite Interactions and Pathogenesis. Curr Clin Microbiol Rep. 2021; 8(2):62-67. PMC: 7868307. DOI: 10.1007/s40588-021-00159-7. View